Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2023 | The limitations and future of precision medicine in sickle cell disease

Sara El Hoss • 23 Apr 2023
BSH 2023
Non-Malignant Sickle Cell Disease

Sara El Hoss, PhD, King’s College, London, UK, discusses the application of precision medicine in sickle cell disease (SCD). She highlights the current limitations for precision medicine and the need for improvement to allow its application in SCD treatment, especially in African populations. This interview was held at the 63rd Annual Scientific Meeting of the British Society for Hematology (BSH) 2023, held in Birmingham, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Sara El Hoss

4:02
Investigating erythropoiesis and the bone marrow niche in SCD
Sara El Hoss • 27 Oct 2023
1:11
Precision medicine in sickle cell disease: current status and future outlooks
Sara El Hoss • 24 Apr 2023

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals